From Principle to Practice

Christian leaders increasingly face difficult questions involving abortion, assisted reproduction, genetic testing, end-of-life care, organ transplantation, gender-related medicine, disability, artificial intelligence, and emerging biotechnology. An effective biomedicine ethics policy must therefore do more than list prohibited procedures. It should help churches, schools, hospitals, and ministries discern how biomedical practices affect human dignity, moral responsibility, suffering, family life, and the common good.

Nicanor Pier Giorgio Austriaco’s Biomedicine and Beatitude: An Introduction to Catholic Bioethics offers a particularly useful framework. Rooted in Scripture, natural law, virtue ethics, and Catholic moral theology, Austriaco approaches bioethics through the vocation of the human person to beatitude—true happiness and flourishing in communion with God. Although Christian traditions differ on ecclesial authority and some moral conclusions, this theological vision can help leaders develop policies that are principled, pastoral, and practically usable.

A Christian bioethics policy should begin by asking not merely, “What can medicine do?” but “What is medicine for, and what kind of life are Christians called to live?”

Austriaco places beatitude at the center of moral reasoning. Human flourishing cannot be reduced to physical health, freedom from pain, personal autonomy, or technological control. Health is a genuine good, but it is not the highest good. Medicine serves the person; the person does not exist simply to preserve biological life or satisfy individual preference.

This perspective protects Christian policy from two opposite errors. The first is technological optimism—the assumption that whatever can be done should be done. The second is therapeutic absolutism—the belief that preserving life or eliminating suffering overrides every other moral consideration. Christian ethics instead understands bodily life as sacred but ordered toward love of God and neighbor.

A policy’s opening statement might therefore affirm:

Christian bioethics begins with the conviction that human worth is inherent rather than earned. Scripture presents human beings as made in the image and likeness of God (Gen. 1:26–27). Consequently, dignity does not depend on intelligence, independence, health, social usefulness, age, wantedness, or stage of development.

Austriaco’s account of the human person draws upon the Catholic understanding of the unity of body and soul. The body is not disposable material or a mere instrument of the will. What is done to the body is done to the person. This principle has implications across biomedical ethics, including embryonic research, reproductive technologies, disability care, sexuality, transplantation, and treatment at the end of life.

An effective policy should explicitly protect human beings who are most vulnerable to neglect or instrumentalization, including:

Such protection should be accompanied by practical commitments to care. A Christian institution should not defend dignity abstractly while failing to provide accompaniment, material assistance, pain relief, disability support, or help for families under pressure.

Leaders need more than good intentions. They need a repeatable process for evaluating biomedical decisions. Drawing on the moral framework presented by Austriaco, a policy should examine at least four areas.

What is actually being chosen? Policies should describe the act precisely rather than relying on motives or euphemisms. For example, withdrawing a burdensome treatment is not necessarily the same moral act as intentionally causing death.

What outcome does the decision-maker seek? A good intention cannot make an intrinsically wrongful act good, but intention remains morally important. Administering medication to control pain while foreseeing—but not intending—a possible shortening of life differs morally from administering medication in order to cause death.

Who may be affected? What burdens, risks, benefits, alternatives, and social effects are present? Circumstances may increase or reduce responsibility and may determine whether an otherwise legitimate treatment is prudent.

Cooperation and institutional witness

Christian organizations often work with governments, insurers, vendors, and professionals whose practices differ from Christian teaching. Policies should distinguish formal cooperation—sharing another’s wrongful intention—from different forms of material cooperation. They should also consider proximity, necessity, scandal, available alternatives, and the institution’s public witness.

This method prevents policies from becoming collections of reactions to controversial procedures. It also equips leaders to address technologies that did not exist when the policy was written.

Rules are necessary, but they are not sufficient. Austriaco’s emphasis on beatitude places virtue at the heart of bioethics. Christian leaders should ask not only, “Is this permitted?” but also, “What would a wise, just, courageous, temperate, faithful, and compassionate person do?”

Virtue is especially important where facts are uncertain or several legitimate goods are in tension. Prudence helps leaders apply moral truth to particular circumstances. Justice asks whether benefits and burdens are distributed fairly. Courage resists institutional, financial, or cultural pressure. Temperance limits the desire for technological mastery. Charity keeps the patient’s genuine good at the center.

Accordingly, policy formation should include spiritual and moral formation. Ethics committees and leaders need habits of prayer, truthful speech, careful listening, confession of conflicts of interest, and willingness to receive correction. A technically sophisticated policy can still fail if implemented by a culture driven by fear, prestige, profit, or political identity.

An effective policy should translate its framework into guidance on recurring issues.

Policies should state when the institution recognizes the beginning of human life and what protections follow from that judgment. They should address abortion, miscarriage care, prenatal diagnosis, fertility treatment, contraception, sterilization, embryo creation and storage, and research involving embryos.

Within the Catholic framework Austriaco presents, procreation should respect both the dignity of the child and the marital meaning of human sexuality. Christian traditions may differ on some applications, but all leaders should examine whether reproductive technologies treat children as gifts to be received or products to be selected, manufactured, stored, or discarded.

Policies should also ensure compassionate support for women facing crisis pregnancies, married couples experiencing infertility, families receiving serious prenatal diagnoses, and parents grieving pregnancy loss.

Genetic technologies can heal disease, but they may also encourage discrimination, eugenics, enhancement, or the treatment of future children as objects of design. A policy should distinguish therapeutic interventions from enhancement and should evaluate whether genetic changes are somatic or heritable.

Questions should include:

Christian teaching neither requires the use of every possible treatment nor permits the intentional killing of patients. A policy should distinguish ordinary or proportionate care from extraordinary or disproportionate treatment. It should recognize that refusing or withdrawing a futile or excessively burdensome intervention can be morally legitimate when death is accepted rather than intended.

At the same time, patients should receive appropriate nutrition and hydration when these provide benefit without disproportionate burden, as well as pain management, spiritual care, human presence, and protection against abandonment. Advance-care planning should identify the patient’s values and decision-makers without authorizing euthanasia or assisted suicide.

Research should satisfy standards of informed consent, scientific validity, proportionality of risk, privacy, and fair subject selection. Vulnerable populations should receive additional protection. Christian institutions should also evaluate the origin of biological materials, including tissues and cell lines, and establish standards for morally responsible cooperation when historical wrongdoing is involved.

Bioethics is not limited to dramatic questions of life and death. It also includes unequal access to ordinary care, racial and economic disparities, neglect of disability, pharmaceutical pricing, global health inequity, and the allocation of scarce resources.

A Christian policy should reject discrimination based on social worth. Allocation criteria should be clinically relevant, transparent, consistently applied, and open to review. Special attention should be given to those who have the least power to advocate for themselves.

A policy becomes effective through governance. Christian organizations should create an interdisciplinary ethics structure that includes, as appropriate:

The group should review difficult cases, provide education, disclose conflicts of interest, and revise policies as science develops. Leaders should document the theological basis, clinical facts, legal context, and reasoning behind major conclusions.

Policies should also establish a consultation pathway for urgent cases. Staff members need to know whom to contact, how quickly guidance will be given, and how conscience concerns will be handled. Conscience protections should be meaningful, while institutions should also ensure that patients are treated honestly, respectfully, and without abandonment.

Christian ethics policies can fail by being either vague or harsh. Vague language leaves staff without guidance. Harsh language may communicate moral conclusions without communicating Christlike care.

Each policy section should therefore contain:

Leaders should also distinguish between binding institutional commitments, prudential recommendations, and matters on which faithful Christians disagree. This promotes honesty and avoids presenting every judgment as possessing the same level of authority.

Before adopting or approving a biomedical practice, Christian leaders should ask:

A Christian biomedicine ethics policy should be more than a defensive response to cultural controversy. It should express a coherent vision of the human person, medicine, suffering, community, and eternal destiny.

Austriaco’s Biomedicine and Beatitude helps leaders recover that larger vision. Biomedical ethics is ultimately not about mastering every technology or avoiding every risk. It is about ordering medicine toward authentic human flourishing under God. Policies shaped by that end will protect life without idolizing biological survival, defend moral truth without abandoning compassion, and welcome scientific progress without surrendering wisdom.

The most effective Christian policy will therefore unite theological conviction, careful moral analysis, scientific competence, pastoral care, accountable governance, and preferential concern for the vulnerable. In doing so, Christian institutions can offer not simply restrictions, but a faithful witness to what medicine is for: the service of persons called to communion, holiness, and beatitude.

Austriaco, Nicanor Pier Giorgio. Biomedicine and Beatitude: An Introduction to Catholic Bioethics. Washington, DC: The Catholic University of America Press, 2011.